Tag: Remogliflozin + Vildagliptin
Glenmark Launch Remogliflozin + Vildagliptin Fixed Dose Combination for Type 2 Diabetes
KOCHI:Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed dose combination.